Malcolm Young awarded Ernst & Young Innovation Entrepreneur Of The Year 2010


Malcolm Young awarded Ernst & Young Innovation Entrepreneur Of The Year 2010


Source: The Guardian - 17/01/07 - View Source Article
Sarah Hall, health correspondent
Scientists believe they have found a cure for the MRSA superbug after unearthing an existing drug on a computer database.
Source: The Sun - 17/01/07 - View Source Article
A DRUG that destroys ALL forms of superbug MRSA has been identified, claim scientists.
The medicine is ALREADY licensed to treat other diseases — but computer simulations found it could target MRSA’s biological weaknesses.
Prof Malcolm Young, of Newcastle University, said it could be a “weapon of mass destruction for MRSA”.
Trials are due to start in two months — and it could be in use within three years.
Source: The Scotsman - 17/01/07 - View Source Article
INCIDENTS of the deadly bug MSSA in Scotland are much higher than previously thought, figures revealed yesterday.
Cases of methicillin-sensitive Staphylococcus aureus (MSSA) - a relative of the MRSA superbug - increased to 377 from July to September last year.
This compared with 300 during the corresponding period in 2005 and 268 the previous quarter, according to Health Protection Scotland (HPS).
Source: Yorkshire Post - 17/01/07 - View Source Article
Scientists say they have found three drugs that kill the MRSA superbug – after developing them on a computer.
New research firm e-Therapeutics says the treat-ment even works on strains of the bug that have defeated the best existing drugs.
The Gazeta Mercantil Brazil's Financial Times, reports the new joint venture between e-Therapeutics and Grupo TCI to screen Brazilian compounds and reinforce Brazilian pharmaceutical manufacturers.
Year 2006 – No. 23,377 - Wednesday 26th July 2006 - Industry: Pharmaceutics
Companies get together to launch a system that speeds research into new medicines Iolanda Nascimento, São Paulo
The Diario de Pernambuco celebrates e-Therapeutics "bringing to Brazil the fastest technology in the world for discovering new medicines" in collaboration with Grupo TCI and CURA.
Friday 28th July 2006, Recife – No. 209 - The Economy
The Folha de Pernambuco reports a new initiative to "develop medicines to treat tropical diseases", bringing e-Therapeutics' technology to bear on Brazilian diseases.
Recife, Friday 28th July 2006 Year 9 No. 205 - The Economy - Health
Private initiative arrives in the pharmaceutical cluster - By Sarah Eleutério
Joint Venture between Grupo TCI and an English company brings the fastest technology in the world for discovering new medicines to Brazil.
Through bioinformatics, e-Therapeutics is able to reduce the research time for the development of new medicines from two years to two weeks for known molecules.
Professor Malcolm Young, Chairman of e-Therapeutics concluding the agreement with the Presidente of Central Única de Remédios Associados (CURA), Romulo Queiroz, in Rio de Janeiro.
e-Therapeutics, the drug discovery enterprise of Inrotis Technologies, wins major mezzanine funding from RAB Special Situations LLP , the world's highest performing investment fund.